Suggestions
Joseph Higgins
President & CSO SalioGen Therapeutics
Joseph Higgins is the Founder and President of SalioGen Therapeutics, a non-viral gene editing company, focused on innovative cell and gene therapies for severe genetic diseases. With a background spanning diverse fields like pediatric medicine, child neurology, and molecular neurobiology, Joseph brings a unique perspective to the healthcare sector. He has made significant scientific contributions, including identifying genes for diseases like Parkinson's and essential tremor, and has led multiple clinical trials in gene therapies. With a double board certification in Pediatrics and Neurology, Joseph holds a medical licensure in New York and Massachusetts. His academic journey includes positions at esteemed institutions like Harvard Medical School and Cornell University, and he has authored numerous publications and holds gene therapy patents. Joseph is also a former VP of Clinical Development at uniQure and has served in various roles at organizations like Quest Diagnostics and the National Institutes of Health.
